Overview of Spinal Muscular Atrophy (SMA) in India

Essential skeletal muscle activities such as breathing, swallowing, walking and speaking are controlled by the motor neurons, which are nerve cells in the brain stem and spinal cord. Spinal muscular atrophy (SMA) dismantles the motor neurons thereby disrupting the communication with the muscles and making them weak. 

Spinal Muscular Atrophy is a hereditary disease in which the affected person has two mutated genes, often inheriting one from each parent (except in rare cases). The affected persons will not show any symptoms if they carry only one mutated gene.

SMA is a common genetic cause of death amongst babies, but people are not aware of it as much as they should be. MedPiper Technologies and JournoMed in association with CureSMA are organising a webinar to create awareness about SMA amongst the families, doctors, and important decision-makers to show the need for the provision of treatment and the highest standards of care for all the SMA-affected children and adults.

Related Articles

The event will be held on 18th September, Saturday, 2 pm. Participants can join the event by registering for it here. For more details, participants may contact Soumya T.S at / 9080078447.

The event will feature Ms. Archana Panda, Co-Founder & Director – Patient Advocacy, CureSMA Foundation of India, as a speaker. 

CureSMA Foundation, which was started in 2014 has the ultimate goal of creating access to the most expensive treatments, and prioritize providing the utmost care for SMA patients, which is the current need.

The event will touch upon the basic idea of SMA, types and some of the common questions that are in the minds of doctors regarding the assessment and treatment of the disease. 

The webinar will also focus on the therapies, necessary equipment and survival chances of affected individuals which will help healthcare professionals to guide the patients with the best possible therapies available in the country.

Update: The post-event summary of the webinar can be accessed here. 

Show More

Related Articles

Leave a Reply

Back to top button